Sonnet BioTherapeutics
SONN
SONN
18 hedge funds and large institutions have $2.63M invested in Sonnet BioTherapeutics in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
Holders
18
Holders Change
+5
Holders Change %
+38.46%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
2
Reduced
2
Closed
4
Calls
$305K
Puts
–
Net Calls
+$305K
Net Calls Change
+$305K
Top Buyers
Top Sellers
1 |
TSS
1
Two Sigma Securities
New York
|
$0 |
2 |
HF
2
HRT Financial
New York
|
$0 |
3 |
3
Mariner
Overland Park,
Kansas
|
$0 |
4 |
4
UBS Group
Zurich,
Switzerland
|
$0 |
5 |
TRCT
5
Tower Research Capital (TRC)
New York
|
$2K |